We are currently updating our website
content.
We apologize for any inconvenience
BT PHARMA is an emerging biopharmaceutical company focused on developing innovative therapeutic vaccines for the treatment of and associated neoplasia caused by human papillomavirus (HPV) .
The company was created in October 2001 and is based in Labège (Toulouse), France.